Treatment-resistant psoriasis presents significant challenges due to persistent inflammation and limited responses to conventional therapies. Targeted biologics, particularly IL-17 and IL-23 inhibitors, ... Nov 02
... Nov 02
Sun Pharma today announced that its wholly-owned Japanese subsidiary has launched ILUMYA Subcutaneous Injection 100 mg Syringe... Sep 23
-Advertisements-